Daratumumab Plus Cyclophosphamide, Bortezomib and Dexamethasone (Dara-CyBorD) in Previously Untreated and Relapsed Subjects With Multiple Myeloma
Phase of Trial: Phase II
Latest Information Update: 15 Oct 2017
At a glance
- Drugs Bortezomib (Primary) ; Cyclophosphamide (Primary) ; Daratumumab (Primary) ; Dexamethasone (Primary) ; Dexamethasone (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 08 Sep 2017 Trial design presented at the 42nd European Society for Medical Oncology Congress.
- 16 Dec 2016 Status changed from not yet recruiting to recruiting.
- 04 Nov 2016 New trial record